PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2143367
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2143367
Specimen Retrieval Bags Market size was valued at US$ 310.8 Million in 2025, expanding at a CAGR of 4.1% from 2026 to 2033.
Specimen retrieval bags are sterile, usually single-use containment devices used in minimally invasive surgery to capture and remove tissue, organs, or calculi during surgery through laparoscopic access sites while minimizing spillage and contamination. The market ranges from simple pouch configurations to systems that incorporate introducers, deployment mechanisms, closure sutures, and support structures; thus, purchasing decisions are driven by port compatibility, bag integrity, visibility, opening control, and ease of specimen extraction. In 2025, SurgSci showcased a disposable retrieval pouch that came in 200 mL, 400 mL, and 600 mL sizes, demonstrating how vendors can tailor the capacity to the size of the specimen while maintaining a 10-mm shaft interface. Thus, the market is shifting to procedure-specific containment designs rather than using retrieval bags as interchangeable accessories.
Specimen Retrieval Bags Market- Market Dynamics
Greater Emphasis on Controlled Specimen Containment During Minimally Invasive Extraction
Specimen extraction is becoming tightly linked to procedural control because surgeons must insert, close, and pull out the containment pouch while keeping the specimen and the surrounding surgical area safe. This need manifests in device designs that integrate deployment and closure functions and work with trocars. In March 2025, the FDA cleared DANNIK's single-use poly specimen retrieval system. This system is designed to fit 10-mm and 12-mm introducer sizes and uses biasing arms to open the pouch before closing it with a suture. This flexibility in design reduces the need for a single access size and focuses more on careful deployment and extraction. The new market push is for containment that matches workflow rather than simply having a pouch.
The Global Specimen Retrieval Bags Market is segmented on the basis of Type, Application, Introducer Size, End User, and Region.
By type, detachable systems allow the bag to separate from the deployment shaft, freeing the trocar pathway for instruments and providing surgeons with more flexibility after the specimen is secured. SurgSci's product documentation explains the release-button separation of the bag from the push-rod assembly. Non-detachable systems keep the pouch and deployment assembly together, simplifying the process when uninterrupted control is needed. The type split difference, therefore, changes instrument management, operating-room workflow, and extraction technique, not just product design. The 2025 FDA clearance of SPI's LaproSac system, which offers both bag and deployment-mechanism configurations, illustrates how important the architectural choice is in the market.
By application, the application requirements change with specimen characteristics, extraction route, contamination concerns, and how much manipulation is needed before removal. Gastrointestinal surgeries usually involve organs such as the gallbladder and appendix. Urological surgeries may need to contain kidneys, prostate tissue, or calculi. Gynecological procedures add concerns about ovarian, uterine, and fibroid specimens. Johnson & Johnson lists its ENDOPOUCH system for laparoscopic removal of the appendix, gallbladder, ovaries, fibroid tumors, other tissues, and calculi, showcasing the range of uses. A 2025 clinical study of 88 patients using retrieval bags during invasive colorectal surgery found that bacterial contamination increased during the procedure and peaked after the specimen was removed. The application diversity makes containment performance a procedure-purchasing decision.
Specimen Retrieval Bags Market- Geographical Insights
North America stands out through its regulatory pathway and established portfolio of minimally invasive surgical-device suppliers. The U.S. FDA classifies specimen retrieval systems within 21 CFR 876.1500, providing a defined route for manufacturers introducing or modifying these devices. The 2025 regulatory record shows continued product activity: Surgical Principals submitted its LaproSac system in June, received a substantially equivalent determination in September, while DANNIK received its determination in March. This activity is significant because regulatory clearance remains closely tied to the commercialization of pouch materials, deployment mechanisms, and access configurations. North America's market role is therefore shaped not just by surgical utilization but also by continuous product qualification and portfolio renewal.
Asia Pacific combines laparoscopic procedure volumes with expanding clinical use across abdominal, gynecological, and urological surgery, creating a broad procedural base for specimen-containment products. Japan provides transparent evidence: the Japan Society for Endoscopic Surgery reported 290,787 patients undergoing endoscopic surgery in 2021, including 124,614 abdominal, 110,757 obstetric and gynecologic, and 21,771 urological procedures; the survey was publicly updated in January 2025. A separate nationwide Japanese study published in 2025 found laparoscopic hysterectomies for disease reached 34,429 cases in 2023, representing 53.4% of hysterectomies in that category. The regional implication is a diversified base where retrieval systems must accommodate varied minimally invasive workflows.
Competition in this field is built upon containment reliability, deployment mechanics, material strength, port compatibility, and the ability to integrate the pouch into a laparoscopic workflow. Johnson & Johnson's ENDOPOUCH relies on support arms that connect to the shaft and introducer, whereas Teleflex's MemoBag employs a nitinol wire that brings the bag rim back to its shape once it is deployed. Applied Medical, CONMED, Surgical Principals, DANNIK, SurgSci, and other suppliers distinguish themselves by varying bag materials, opening mechanisms, detachability, and access-system design rather than focusing solely on the pouch. Regulatory activity reinforces this product-level competition as FDA records reveal that both DANNIK and Surgical Principals received equivalent determinations in 2025. Competitive differentiation is now shifting toward controlled deployment and procedural integration.
In March 2025, the FDA cleared DANNIK's DANNIK(R) Laparoscopic Single-Use Poly Specimen Retrieval System on March 12, 2025. The DANNIK system offers bag volumes from 120 mL to 1,500 mL across its configurations. This FDA clearance strengthens the market focus on single-use retrieval systems that can handle a range of specimen sizes.
In April 2025, SurgSci announced that SurgSci's Disposable Specimen Retrieval Bag received EU MDR certification in April 2025. The certification covered SurgSci's specimen retrieval bag with SurgSci's disposable laparoscopic trocar and SurgSci's Veress needles, showing three device categories in the announcement.